NRMT knockdown is demonstrated to enhance the chemosensitivity of retinoblastoma cells to CDDP; this aspect of the present study could potentially pave the way for future studies to explore novel therapeutic targets in preventing chemoresistance. The gene discussed is NTMT1; the disease is retinoblastoma.